WO2003030722A3 - Magnetic field enhancement of tumor treatment - Google Patents

Magnetic field enhancement of tumor treatment Download PDF

Info

Publication number
WO2003030722A3
WO2003030722A3 PCT/US2002/032444 US0232444W WO03030722A3 WO 2003030722 A3 WO2003030722 A3 WO 2003030722A3 US 0232444 W US0232444 W US 0232444W WO 03030722 A3 WO03030722 A3 WO 03030722A3
Authority
WO
WIPO (PCT)
Prior art keywords
magnetic field
tumor treatment
field enhancement
tumor
mtesla
Prior art date
Application number
PCT/US2002/032444
Other languages
French (fr)
Other versions
WO2003030722A2 (en
Inventor
Robert E Sandstrom
Original Assignee
Robert E Sandstrom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert E Sandstrom filed Critical Robert E Sandstrom
Priority to GB0408373A priority Critical patent/GB2396302B/en
Priority to CA2463491A priority patent/CA2463491C/en
Priority to AU2002343495A priority patent/AU2002343495A1/en
Publication of WO2003030722A2 publication Critical patent/WO2003030722A2/en
Publication of WO2003030722A3 publication Critical patent/WO2003030722A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Abstract

A method of treating a tumor, comprising creating an elevated concentration of free radicals in said tumor (22) and creating a magnetic field (20) that traverses said tumor (22) and that inhibits the recombination of said free radicals in said tumor. A magnetic field of 0.1 mTesla to 10 mTesla is generally used for this purpose.
PCT/US2002/032444 2001-10-11 2002-10-09 Magnetic field enhancement of tumor treatment WO2003030722A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0408373A GB2396302B (en) 2001-10-11 2002-10-09 Magnetic field enhancement of tumor treatment
CA2463491A CA2463491C (en) 2001-10-11 2002-10-09 Magnetic field enhancement of tumor treatment
AU2002343495A AU2002343495A1 (en) 2001-10-11 2002-10-09 Magnetic field enhancement of tumor treatment

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32808501P 2001-10-11 2001-10-11
US60/328,085 2001-10-11
US34927002P 2002-01-18 2002-01-18
US60/349,270 2002-01-18

Publications (2)

Publication Number Publication Date
WO2003030722A2 WO2003030722A2 (en) 2003-04-17
WO2003030722A3 true WO2003030722A3 (en) 2003-07-03

Family

ID=26986208

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/032444 WO2003030722A2 (en) 2001-10-11 2002-10-09 Magnetic field enhancement of tumor treatment

Country Status (4)

Country Link
AU (1) AU2002343495A1 (en)
CA (1) CA2463491C (en)
GB (1) GB2396302B (en)
WO (1) WO2003030722A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2855067B1 (en) 2003-05-20 2005-06-24 Emery Sa SNOW SURF MOUNTING
CN107362445A (en) * 2017-08-30 2017-11-21 东北师范大学 Anticancer targeting medicine points to electrostatic field resultant vector intensifier
WO2019120489A1 (en) * 2017-12-19 2019-06-27 Medical Development Technologies S.A. Heatable implant device for tumor treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665898A (en) * 1984-05-23 1987-05-19 Maxwell Laboratories, Inc. Malignancy treatment
US5156587A (en) * 1983-09-01 1992-10-20 Montone Liber J Method for treating malignant cells
US6261831B1 (en) * 1999-03-26 2001-07-17 The United States Of America As Represented By The Secretary Of The Air Force Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163724D1 (en) * 1980-04-29 1984-06-28 Electro Biology Inc Apparatus for treating an intact animal organism bearing a neoplastic process and undergoing drug treatment
WO1997004830A1 (en) * 1995-07-28 1997-02-13 Gray James R Use of a polarizing field to modify the efficacy of a bioactive agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156587A (en) * 1983-09-01 1992-10-20 Montone Liber J Method for treating malignant cells
US4665898A (en) * 1984-05-23 1987-05-19 Maxwell Laboratories, Inc. Malignancy treatment
US6261831B1 (en) * 1999-03-26 2001-07-17 The United States Of America As Represented By The Secretary Of The Air Force Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat

Also Published As

Publication number Publication date
WO2003030722A2 (en) 2003-04-17
GB2396302A (en) 2004-06-23
CA2463491C (en) 2011-07-26
GB0408373D0 (en) 2004-05-19
GB2396302B (en) 2006-05-31
AU2002343495A1 (en) 2003-04-22
CA2463491A1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
AU2592600A (en) Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
WO2001090129A3 (en) Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
ZA200206612B (en) Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction.
AU6363199A (en) Treatment using oriented unidirectional dc magnetic field
AU2003221684A1 (en) Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
EP1295590A3 (en) Two-component agent with a temporary pH gradient and process for treating hair
DE60212613D1 (en) DOXYCYCLIN FOR THE TREATMENT OF ACNE
DE602004022285D1 (en) METHOD FOR THE TREATMENT OF DISEASES WITH HSP90-INHIBITING AGENTS COMBINED WITH ANTIMITOTICS
MXPA03008582A (en) Agents and methods for treatment of cancer.
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
WO2003063725A3 (en) Methods of preventing and treating flavivirus infection in animals
WO2003030722A3 (en) Magnetic field enhancement of tumor treatment
ATE461515T1 (en) METHOD FOR REDUCING NOISE IN A HEARING AID AND HEARING AID FUNCTIONING ACCORDING TO SUCH A METHOD
ATE359808T1 (en) USE OF SARP-1 TO TREAT AND/OR PREVENT SCLERODERMA
DE69818809D1 (en) METHOD FOR TREATING SCAR TISSUE
EP1390064A4 (en) Method of treating malignancies through induction of blood immune responses
ATE291425T1 (en) R-ELIPRODIL FOR THE TREATMENT OF GLAUCOMA
WO2005000203A3 (en) Methods for treating cognitive impairment and improving cognition
SG102679A1 (en) Surface treatment method and material treated by the method
WO1996036339A3 (en) Use of dihydrotestosterone compounds for treating male sexual dysfunction
SE9301606D0 (en) COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH
AU3295495A (en) Method for the treatment or prophylaxis of endo- and ectoparasitic infestations in dogs
UA36485A (en) METHOD OF TREATMENT OF GENERALIZED PERIODONTITIS
UA43641A (en) Method of treating chronic pyelonephritis
RU2001133205A (en) A method for determining the effectiveness of the treatment of chronic prostatitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 0408373

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20021009

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2463491

Country of ref document: CA

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP